Predicting epilepsy after new onset refractory status epilepticus due to autoimmune encephalitis: The DAME score
Epilepsia · 2026-04 · 67 (4) · 1792-1801
DOI: 10.1002/epi.70081 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Epilepsia, online erschienen am 30.12.2025. Verfasst von Simona Lattanzi und 20 weiteren Autor:innen. Beteiligte Einrichtung: Neurological Clinic, Department of Experimental and Clinical Medicine, Polytechnic University of Marche, Ancona, Italy. Hauptthemen laut MEDLINE: Status Epilepticus, Encephalitis, Hashimoto Disease, Drug Resistant Epilepsy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ricerca Corrente, #NEXTGENERATIONEU (NGEU), NextGenerationEU.
Abstract (Originalsprache)
Objective
This study aimed to identify risk factors and develop a predictive scoring system for autoimmune‐associated epilepsy in subjects with autoimmune encephalitis presenting with new onset refractory status epilepticus (NORSE).
Methods
This retrospective, multicenter, cohort study included subjects who presented with NORSE at the onset of autoimmune encephalitis and had at least 24 months of follow‐up after immunotherapy. The outcome was the development of autoimmune‐associated epilepsy, defined as persistent seizures despite adequate immunotherapy and absence of active inflammation. Factors independently associated with the outcome were identified through a backward stepwise selection. Adjusted regression coefficients of each independent predictor were transformed to produce a points‐based risk‐scoring system.
Results
Seventy participants were included (median age = 24.2 years, 38.6% male). During a median follow‐up of 53 months, 54.3% of subjects developed autoimmune‐associated epilepsy. Status epilepticus duration ≥ 10 days (odds ratio [OR] = 31.14, 95% confidence interval [CI] = 2.12–456.87, p = .012), positivity for antibodies against surface antigens (OR = .12, 95% CI = .02–.85, p = .034), bitemporal magnetic resonance imaging (MRI) abnormalities suggestive of autoimmune encephalitis during acute stage (OR = 49.80, 95% CI = 2.95–841.77, p = .007), and interictal epileptiform discharges during electroencephalographic (EEG) follow‐up (OR = 71.32, 95% CI = 6.48–785.32, p < .001) were independently associated with the study outcome. The duration–antibodies–MRI–EEG (DAME) score was developed as an integer‐based scoring system predictive of autoimmune‐associated epilepsy. With an optimal cutoff of ≥3 points, it yielded a sensitivity of 86.8%, a specificity of 87.5%, and an overall accuracy of 87.1%. Significance The DAME score could serve as a user‐friendly score to predict the risk of autoimmune‐associated epilepsy in patients with NORSE due to autoimmune encephalitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neurological Clinic, Department of Experimental and Clinical Medicine, Polytechnic University of Marche, Ancona, Italy.
- Department of Pediatrics, University of Chieti, Chieti, Italy.
- Department of Medicine, University of Udine, Udine, Italy.
- Clinical Neurology, Department of Head-Neck and Neuroscience, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
- Pediatric Neurology and Neurophysiology Unit, Department of Women's and Children's Health, University Hospital of Padua, Neuroimmunology Group, Pediatric Research Institute "Città Della Speranza", Padua, Italy.
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
ORCID-Profile: Simona Lattanzi, Sara Matricardi, Alberto Vogrig, Giada Pauletto, Margherita Nosadini, Stefano Sartori, Federico Massa, Luana Benedetti, Stefano Meletti, Francesca Bisulli, Elena Freri, Francesca Felicia Operto, Sara Mariotto, Simone Beretta, Eleonora Rosati, Elisabetta Cesaroni, Carla Marini, Tiziana Granata, Flavio Villani
Förderung
- Ricerca Corrente
- #NEXTGENERATIONEU (NGEU)
- NextGenerationEU
Zitieren
APA
Lattanzi, S., Matricardi, S., Vogrig, A., Pauletto, G., Nosadini, M., Sartori, S., Massa, F., Benedetti, L., Meletti, S., Bisulli, F., Freri, E., Operto, F. F., Bozzetti, S., Mariotto, S., Beretta, S., Rosati, E., Cesaroni, E., Marini, C., Granata, T., …, & Immune Epilepsies Study Group of the Italian League Against Epilepsy (2026). Predicting epilepsy after new onset refractory status epilepticus due to autoimmune encephalitis: The DAME score. Epilepsia, 67(4), 1792-1801. https://doi.org/10.1002/epi.70081
Vancouver
Lattanzi S, Matricardi S, Vogrig A, Pauletto G, Nosadini M, Sartori S, et al. Predicting epilepsy after new onset refractory status epilepticus due to autoimmune encephalitis: The DAME score. Epilepsia. 2026;67(4):1792-1801. doi:10.1002/epi.70081
BibTeX
@article{Lattanzi2026,
author = {Lattanzi, Simona and Matricardi, Sara and Vogrig, Alberto and Pauletto, Giada and Nosadini, Margherita and Sartori, Stefano and Massa, Federico and Benedetti, Luana and Meletti, Stefano and Bisulli, Francesca and Freri, Elena and Operto, Francesca Felicia and Bozzetti, Silvia and Mariotto, Sara and Beretta, Simone and Rosati, Eleonora and Cesaroni, Elisabetta and Marini, Carla and Granata, Tiziana and Villani, Flavio and Immune Epilepsies Study Group of the Italian League Against Epilepsy, Immune Epilepsies Study Group of the Italian League Against Epilepsy},
title = {Predicting epilepsy after new onset refractory status epilepticus due to autoimmune encephalitis: The DAME score},
journal = {Epilepsia},
year = {2026},
volume = {67},
number = {4},
pages = {1792--1801},
doi = {10.1002/epi.70081}
}
EUVIMED